Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 1
2004 1
2005 2
2007 1
2010 3
2011 4
2012 3
2013 3
2014 3
2015 2
2016 3
2017 2
2018 3
2019 4
2020 2
2021 6
2022 1
2023 9
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Results by year

Filters applied: . Clear all
Page 1
Immunogenicity phase II study evaluating booster capacity of nonadjuvanted AKS-452 SARS-Cov-2 RBD Fc vaccine.
Alleva DG, Feitsma EA, Janssen YF, Boersma HH, Lancaster TM, Sathiyaseelan T, Murikipudi S, Delpero AR, Scully MM, Ragupathy R, Kotha S, Haworth JR, Shah NJ, Rao V, Nagre S, Ronca SE, Green FM, Shaw SA, Aminetzah A, Kruijff S, Brom M, van Dam GM, Zion TC. Alleva DG, et al. Among authors: boersma hh. NPJ Vaccines. 2024 Feb 21;9(1):40. doi: 10.1038/s41541-024-00830-2. NPJ Vaccines. 2024. PMID: 38383578 Free PMC article.
[15O]H2O PET: Potential or Essential for Molecular Imaging?
Slart RHJA, Martinez-Lucio TS, Boersma HH, Borra RH, Cornelissen B, Dierckx RAJO, Dobrolinska M, Doorduin J, Erba PA, Glaudemans AWJM, Giacobbo BL, Luurtsema G, Noordzij W, van Sluis J, Tsoumpas C, Lammertsma AA. Slart RHJA, et al. Among authors: boersma hh. Semin Nucl Med. 2023 Aug 26:S0001-2998(23)00070-3. doi: 10.1053/j.semnuclmed.2023.08.002. Online ahead of print. Semin Nucl Med. 2023. PMID: 37640631 Free article. Review.
Quantification of P-glycoprotein function at the human blood-brain barrier using [18F]MC225 and PET.
Mossel P, Arif WM, De Souza GS, Varela LG, van der Weijden CWJ, Boersma HH, Willemsen ATM, Boellaard R, Elsinga PH, Borra RJH, Dierckx RAJO, Lammertsma AA, Bartels AL, Luurtsema G. Mossel P, et al. Among authors: boersma hh. Eur J Nucl Med Mol Imaging. 2023 Nov;50(13):3917-3927. doi: 10.1007/s00259-023-06363-5. Epub 2023 Aug 8. Eur J Nucl Med Mol Imaging. 2023. PMID: 37552369 Free PMC article.
Oral administration of PET tracers: Current status.
Salvi de Souza G, Mantovani DBA, Mossel P, Haarman BCM, Marques da Silva AM, Boersma HH, Furini CRG, Lammertsma AA, Tsoumpas C, Luurtsema G. Salvi de Souza G, et al. Among authors: boersma hh. J Control Release. 2023 May;357:591-605. doi: 10.1016/j.jconrel.2023.04.008. Epub 2023 Apr 23. J Control Release. 2023. PMID: 37031742 Free article. Review.
A randomized phase I/II safety and immunogenicity study of the Montanide-adjuvanted SARS-CoV-2 spike protein-RBD-Fc vaccine, AKS-452.
Feitsma EA, Janssen YF, Boersma HH, van Sleen Y, van Baarle D, Alleva DG, Lancaster TM, Sathiyaseelan T, Murikipudi S, Delpero AR, Scully MM, Ragupathy R, Kotha S, Haworth JR, Shah NJ, Rao V, Nagre S, Ronca SE, Green FM, Aminetzah A, Sollie F, Kruijff S, Brom M, van Dam GM, Zion TC. Feitsma EA, et al. Among authors: boersma hh. Vaccine. 2023 Mar 24;41(13):2184-2197. doi: 10.1016/j.vaccine.2023.02.057. Epub 2023 Feb 23. Vaccine. 2023. PMID: 36842886 Free PMC article. Clinical Trial.
51 results